| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▼ | 1.05▼ | 1.05▼ | 1.14▼ | 1.47▼ |
| MA10 | 1.05▼ | 1.05▼ | 1.06▼ | 1.13▼ | 1.71▼ |
| MA20 | 1.05▼ | 1.06▼ | 1.11▼ | 1.40▼ | 1.99▼ |
| MA50 | 1.06▼ | 1.14▼ | 1.15▼ | 1.73▼ | 7.44▼ |
| MA100 | 1.11▼ | 1.15▼ | 1.13▼ | 2.08▼ | 13.76▼ |
| MA200 | 1.17▼ | 1.17▼ | 1.66▼ | 4.16▼ | 19.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.002▲ | -0.007▼ | -0.005▼ | 0.291▲ |
| RSI | 37.732▼ | 35.254▼ | 33.846▼ | 35.484▼ | 31.717▼ |
| STOCH | 26.389 | 45.076 | 20.268 | 53.693 | 27.075 |
| WILL %R | -100.000▼ | -90.909▼ | -97.297▼ | -88.333▼ | -98.491▼ |
| CCI | -156.154▼ | -140.541▼ | -98.990 | -107.002▼ | -134.344▼ |
|
Wednesday, December 04, 2024 11:50 PM
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused ...
|
|
Wednesday, November 27, 2024 11:28 PM
HC Wainwright restated their neutral rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) in a report issued on Monday,Benzinga reports. HC Wainwright also issued estimates for RAPT ...
|
|
Wednesday, November 27, 2024 11:28 PM
HC Wainwright restated their neutral rating on shares of RAPT Therapeutics (NASDAQ:RAPT – Free Report) in a report issued on Monday,Benzinga reports. HC Wainwright also issued estimates for RAPT ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/24 | 1.04 | 1.07 | 1.02 | 1.035 | 459,457 |
| 04/12/24 | 1.19 | 1.22 | 1.05 | 1.055 | 639,233 |
| 03/12/24 | 1.15 | 1.25 | 1.1318 | 1.20 | 294,157 |
| 02/12/24 | 1.25 | 1.27 | 1.15 | 1.155 | 288,224 |
| 29/11/24 | 1.23 | 1.2795 | 1.21 | 1.26 | 180,690 |
| 27/11/24 | 1.12 | 1.26 | 1.12 | 1.23 | 609,495 |
| 26/11/24 | 1.12 | 1.17 | 1.11 | 1.12 | 215,234 |
| 25/11/24 | 1.11 | 1.20 | 1.11 | 1.12 | 684,950 |
| 22/11/24 | 1.04 | 1.12 | 1.04 | 1.08 | 498,374 |
| 21/11/24 | 1.05 | 1.07 | 1.00 | 1.05 | 546,961 |
|
|
||||
|
|
||||
|
|